Related Experiment Videos
Advances in alcoholic liver disease
Gavin Arteel1, Luis Marsano, Christian Mendez
1University of Louisville Medical Center, Building A, Room 1319, Louisville, KY 40292, USA.
Best Practice & Research. Clinical Gastroenterology
|June 28, 2003
Summary
Alcoholic liver disease (ALD) is a significant global health issue. Management involves lifestyle changes, nutritional support, and targeted therapies like corticosteroids or pentoxifylline for specific conditions.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Alcoholic liver disease (ALD) is a leading cause of illness and death globally.
- High mortality rates are observed in patients with cirrhosis and alcoholic hepatitis.
- Pathogenesis involves complex interactions of acetaldehyde, oxidative stress, inflammation, and genetics.
Purpose of the Study:
- To review current therapeutic strategies for alcoholic liver disease.
- To highlight the role of lifestyle modifications and nutritional interventions.
- To discuss pharmacological and complementary treatments for ALD and its complications.
Main Methods:
- Literature review of existing studies on ALD treatment.
- Analysis of therapeutic approaches including lifestyle changes, nutrition, and medications.
- Evaluation of complementary and alternative medicine (CAM) agents.
Main Results:
- Lifestyle modifications (cessation of alcohol/smoking, weight loss) are foundational.
- Nutritional intervention positively impacts patient outcomes.
- Corticosteroids and pentoxifylline show efficacy in specific ALD presentations.
- CAM agents like milk thistle and S-adenosylmethionine may benefit alcoholic cirrhosis.
Conclusions:
- Comprehensive management of ALD requires a multi-faceted approach.
- Early intervention and adherence to treatment improve prognosis.
- Further research into novel therapies is warranted to reduce ALD morbidity and mortality.